What they were paid
Xenon Pharmaceuticals Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $92,890 | $81,281 | $324,752 | $0 | $498,923 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Xenon Pharmaceuticals Inc. DEF 14A filed April 22, 2026, accession 0001193125-26-170320, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Xenon Pharmaceuticals pays directors a $50,000 cash retainer and $440,000 in Options and/or RSUs.
Committees
FY2025 · as the proxy prints themNominating/Governance (Chair)
The rest of the Xenon Pharmaceuticals board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Elizabeth Garofalo | Independent Director | $458,923 |
| Gary Patou | Independent Director | $461,423 |
| Gillian Cannon | Independent Director | $458,923 |
| Ian Mortimer | Director | $0 |
| Justin Gover | Independent Director | $478,923 |
| Patrick Machado | Independent Director | $471,423 |
| Steven Gannon | Independent Director | $473,923 |
The full Xenon Pharmaceuticals compensation record
free company briefThis page is one director within Xenon Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat